Change of executive director
Filed with HKEX · Stock code 2487 · · 3 pages · English
(Incorporated in the Cayman Islands with limited liability) (Stock Code: 2487) CHANGE OF EXECUTIVE DIRECTOR RESIGNATION OF EXECUTIVE DIRECTOR The Board of Directors (the “Board”) of Cutia Therapeutics (the “Company”, together with its subsidiaries, the “Group”) announces that Mr. Huang Yuqing (“Mr. Huang”) has resigned as an executive director of the Company (the “Director”) and the chief financia
Earlier from Cutia Therapeutics
- 2026 Interim Report
- Voluntary announcement - CU-40102 (topical finasteride spray) obtained marketing approval by the macao pharmaceutical administration bureau
- Poll results of the annual general meeting held on 26 June 2026
Later from Cutia Therapeutics
- List of directors and their roles and functions
- Voluntary announcement - share repurchase program under the share repurchase mandate
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Next Day Disclosure Return
- Voluntary announcement - latest update on the cooperation with rejuven
Follow Cutia Therapeutics into a list and get an email when it puts out news.
Follow Cutia Therapeutics